Robert Bonomo, MD

Associate Professor of Medicine Director Cleveland VAMC GRECC
Phone: (216) 991-3800 ext 4399
Fax: (216) 241-3482
E-mail: robert.bonomo@med.va.gov
Education
BA-Hamilton College, 1976
MD-Case Western Reserve University School of Medicine, 1983
Residecny- University Hospitals of Cleveland, 1986
Infectious Diseases, University Hospitals of Cleveland,1994
Research
Among the major problems faced in medicine, resistance to antibiotics is regarded as a singular challenge. The primary focus of our laboratory is to understand the genetic and amino acid sequence determinants of the enzymes that inactivate ß-lactams, the ß-lactamases. Our current work is directed at solving three main problems:
(i) how ß-lactamase inhibitors inactivate -lactamases;
(ii) how ß-lactamases hydrolyze advanced generation cephalosporins; and
(iii) how mutations impact upon ß-lactamase expression. We are also interested in how penicillin interacts with penicillin resistant PBPs and the molecular epidemiology of extended spectrum ß-lactamases (ESBLs).
Lab Members: Andrea M. Hujer, Christopher R. Bethel
Collaborators: Dr. Marion S. Helfand, Dr. Curtis J. Donskey, Dr. Louis B. Rice, Dr. David L. Paterson, Dr. Focco van den Akker, Dr. Paul R. Carey, Dr. Vernon E. Anderson, Dr. James R. Knox, Dr. Malcolm Page, Dr. Lily Ng, Dr. John Buynak, Dr. Shu Chen, Dr. Michael Kinter, Dr. Anthony Fink, Dr. John Quinn.

Selected References:
• Helfand MS, Hujer AM, and Sonnichsen FD, Bonomo RA. Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV beta-lactamase. J Biol Chem. 2002 Dec 6; 277(49):47719-47723.
• Helfand MS, Bethel CR, Hujer AM, Hujer KM, Anderson VE, Bonomo RA. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of Ser130. J Biol Chem. 2003 Dec 26; 278(52):52724-52729.
• Pagan-Rodriguez D, Zhou X, Simmons R, Bethel, CR, Hujer AM, Helfand MS, Jin Z, Guo B, Anderson VE, Ng LM, Bonomo RA. Tazobactam inactivation of SHV-1 and the inhibitor resistant Ser130Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition. J Biol Chem. 2004 Feb 6 [Epub ahead of print].
• Hujer AM, Bethel CR, Bonomo RA. Antibody mapping of the linear epitopes of CMY-2 and SHV-1 beta-lactamases. In press. Antimicrob Agents Chemother. 2004
|